Therapeutic Apheresis - A US Market Review

1.METHODOLOGY
Study Reliability and Reporting Limitations
Disclaimers
Quantitative Techniques & Reporting Level
2.MARKET ANALYSIS
A Promising Outlook
3.MARKET TRENDS
Apheresis Process Leads to Rise in Platelet Donors
Therapeutic Apheresis Devices – A Perplexing Market
Plateletpheresis: The Treatment of Choice for Patients
Photopheresis Market Growing at a High Rate
Vendors’ Attitude Hampers Growth Prospects of Therapeutic Apheresis
Developing New Applications for Therapeutic Apheresis is the Need of the Hour
CFA – An Effective Way to Pull Up Cold Hemagglutinin Disease
4.COMPETITIVE SCENARIO
Overview
Technology: The Only Key for Success
CaridianBCT: The World Leader
Market Share Trends in the Recent Past
By Procedures (Revenues)
By Procedures (Number of Procedures)
By Neurology Disorders (Revenues)
By Neurology Disorders (Number of Procedures)
By Hematology and Oncology Disorders (Revenues)
By Hematology and Oncology (Number of Procedures)
5.MARKET OVERVIEW & OUTLOOK
Market Drivers
New Reimbursement Policies Create Growth Opportunities for Therapeutic Apheresis
Increased Industry Consolidation Drives Research
Development of New Technology
Research Unveils Novel Applications
Market Restraints
Lack of Awareness Restrains Growth
Therapeutic Apheresis Costs Still a Concern
Market Challenges
Development of Inexpensive Apheresis Therapy
Scarcity of Qualified Donors
Pediatry: An Untapped Opportunity
6.REGULATORY ENVIRONMENT
7.PRODUCT FACTS
Plasmapheresis
Immunoadsorption
Erythrocytapheresis
Plateletpheresis
Leukapheresis
Photopheresis
Lipidpheresis
8.PRODUCT TRENDS AND ISSUES
Therapeutic Plasmapheresis with Fresh Frozen Plasma (FFP) Replacement
Risks Associated with Therapeutic Apheresis
Categories of Indications for Therapeutic Apheresis
Plasma Exchange and Plasmapheresis: The Difference
Applications of Plasma Exchange
Chronic Diseases
Acute Self-Limited Disease
Emerging Applications
9.CORPORATE DEVELOPMENTS
Gambro to Change Name to CaridianBCT
Therakos Obtains CE Mark in Europe
Baxter Divests Transfusion Therapies Business
SCSG Gets Hold of Fresenius Medical Care Extracorporeal Alliance
Rheologics Technologies Takes Over Cardiodyne Electronics
Biotest Obtains Business Unit of Nabi BioPharmaceuticals
Gambro BCT Receives FDA Clearance for Spectra Optia System
MedaSorb Receives Rights for Blood Processing
10.MAJOR PLAYERS
Baxter Healthcare Corporation
CaridianBCT, Inc.
Fenwal, Inc.
Fresenius Medical Care North America (FMCNA)
Haemonetics Corporation
HemaCare Corporation
Hospital Clinical Services Group, Inc. (HCSG)
Therakos, Inc
11.MARKET ANALYTICS
Exhibits
Table 1: Percentage Breakdown of Leading Players in the US Market for Therapeutic Apheresis –
Table 2: Percentage Breakdown of Leading Players in the US Market for Therapeutic Apheresis –
Table 3: Percentage Breakdown of Leading Players in the US Market for Therapeutic Apheresis in Neurological Disorders –
Table 4: Percentage Breakdown of Leading Players in the US Market for Therapeutic Apheresis in Neurological Disorders –
Table 5: Percentage Breakdown of Leading Players in the US Market for Therapeutic Apheresis in Hematology and Oncology Disorders –
Table 6: Percentage Breakdown of Leading Players in the US Market for Therapeutic Apheresis in Hematology and Oncology Disorders –
Table 7: Therapeutic Apheresis Market by Procedure in the US: 2007-2015 (Sales in US$ Thousand)
Table 8: Percentage Breakdown of Therapeutic Apheresis Market by Procedure in the US for the Years 2008 & 2009
Table 9: Therapeutic Apheresis Market by End Use in the US: 2007-2015 (Sales in US$ Thousand)
Table 10: Percentage Breakdown of Therapeutic Apheresis Market by End Use in the US for the Years 2008 & 2009
Companies Profiled